BLOG

5 Tips for Improving Data Analysis

The challenge of Big Data and Manual Analytical Methodologies continues to grow. With Big Data enterprise adoption rates increasing from year to year, companies face the daunting task of integrating and making sense of all this new information.…

The Changing World of Managed Markets

As anyone that has visited a doctor or pharmacy has experienced, the days of a doctor selecting his preferred branded drug, with no oversight, are over. With payers and PBMs systematically exerting more and more control over the drug writing…

Managing Multiple Drug Launches

,
Traditionally Pharma companies used to launch one or two blockbuster assets a year. This resulted in a one-size-fits-all approach to their launches regarding positioning, go-to-market strategy and resourcing. Today the pharmaceutical industry…

Optimizing Life Science Analytical Solutions – Part 2

,
Analytical Solutions are ultimately about improving business performance. If your solution is underutilized, chances are it isn’t useful enough. In our previous blog, we discussed some ways to substantially improve analytics performance for…

Optimizing Life Science Analytical Solutions – Part 1

So you've invested a lot of time and effort in developing a Life Science commercial analytics solution to monitor the market performance of your drug or medical device. Are you getting what you expected from the investment? Obviously, the goal…

How to Choose an Analytics Solution for Your Next Drug Launch

To succeed today, pharmaceutical companies must be highly responsive to rapid changes in customer behavior and market dynamics, especially when introducing a new drug to the market. Many organizations, however, find themselves overwhelmed by…

Reflections on Bayer’s 2014 Plan of Action Event

, , ,
Last week was a truly invigorating experience. Along with Doron Aspitz, Verix’s CEO and Yaron Makleff, Director of Services, I attended Bayer’s annual POA (Plan of Action) event at the Rosen Shingle Creek hotel in Orlando, FL. Bayer’s…

Four common mistakes when planning a new drug launch …..and how to avoid them

In the fiercely competitive Life Sciences market, the launch period of a new drug or medical device is most critical to its overall success. Alas, there is a lot of uncertainty and ambiguity during the first months of any new product in the…